Original Article

Oncogene (2006) 25, 176–185. doi:10.1038/sj.onc.1209049; published online 19 September 2005

Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

H Ota1,2, E Tokunaga1,3, K Chang1, M Hikasa1, K Iijima2, M Eto2, K Kozaki2, M Akishita2, Y Ouchi2 and M Kaneki1,3

  1. 1Department of Anesthesia & Critical Care, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
  2. 2Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo, Tokyo, Japan
  3. 3Shriners Hospital for Children, Boston, MA, USA

Correspondence: Dr M Kaneki, Department of Anesthesia & Critical Care, Massachusetts General Hospital, Harvard Medical School, 149 Thirteenth Street, Rm 6604, Charlestown, MA 02129, USA. E-mail: mkaneki@partners.org

Received 23 June 2005; Accepted 8 July 2005; Published online 19 September 2005.

Top

Abstract

The induction of senescence-like growth arrest has emerged as a putative contributor to the anticancer effects of chemotherapeutic agents. Clinical trials are underway to evaluate the efficacy of inhibitors for class I and II histone deacetylases to treat malignancies. However, a potential antiproliferative effect of inhibitor for Sirt1, which is an NAD+-dependent deacetylase and belongs to class III histone deacetylases, has not yet been explored. Here, we show that Sirt1 inhibitor, Sirtinol, induced senescence-like growth arrest characterized by induction of senescence-associated beta-galactosidase activity and increased expression of plasminogen activator inhibitor 1 in human breast cancer MCF-7 cells and lung cancer H1299 cells. Sirtinol-induced senescence-like growth arrest was accompanied by impaired activation of mitogen-activated protein kinase (MAPK) pathways, namely, extracellular-regulated protein kinase, c-jun N-terminal kinase and p38 MAPK, in response to epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I). Active Ras was reduced in Sirtinol-treated senescent cells compared with untreated cells. However, tyrosine phosphorylation of the receptors for EGF and IGF-I and Akt/PKB activation were unaltered by Sirtinol treatment. These results suggest that inhibitors for Sirt1 may have anticancer potential, and that impaired activation of Ras–MAPK pathway might take part in a senescence-like growth arrest program induced by Sirtinol.

Keywords:

Sirt1, Sirtinol, cellular senescence, Ras, MAPK, Akt/PKB

Extra navigation

.

naturejobs

ADVERTISEMENT